Evidence map›Paper›PMID 37887404›Full record

ArticleMetabolites2023

Urinary Metabolic Distinction of Niemann-Pick Class 1 Disease through the Use of Subgroup Discovery.

Cristóbal J Carmona, Manuel German-Morales, David Elizondo, Victor Ruiz-Rodado, Martin Grootveld

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Cristóbal J CarmonaAndalusian Research Institute on Data Science and Computational Intelligence, University of Jaen, 23071 Jaen, Spain.ORCID 0000-0001-7008-5378
Manuel German-MoralesAndalusian Research Institute on Data Science and Computational Intelligence, University of Jaen, 23071 Jaen, Spain.ORCID 0009-0005-1029-4510
David ElizondoSchool of Computer Science and Informatics, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0002-7398-5870
Victor Ruiz-RodadoPivotal Contract Research Organisation, Community of Madrid, Calle Gobelas 19, La Florida, 28023 Madrid, Spain.
Martin GrootveldLeicester School of Pharmacy, De Montfort University, The Gateway, Leicester LE1 9BH, UK.ORCID 0000-0003-1502-3734
De Montfort University · GBUniversidad de Jaén · ESPivotal (Spain) · ES

Funding

Ministry of Science, Innovation and Universities, Spain PID2019-107793GB-I00/AEI/10.13039/501100011033
6 · The paper itself

Abstract

In this investigation, we outline the applications of a data mining technique known as Subgroup Discovery (SD) to the analysis of a sample size-limited metabolomics-based dataset. The SD technique utilized a supervised learning strategy, which lies midway between classificational and descriptive criteria, in which given the descriptive property of a dataset (i.e., the response target variable of interest), the primary objective was to discover subgroups with behaviours that are distinguishable from those of the complete set (albeit with a differential statistical distribution). These approaches have, for the first time, been successfully employed for the analysis of aromatic metabolite patterns within an NMR-based urinary dataset collected from a small cohort of patients with the lysosomal storage disorder Niemann-Pick class 1 (NPC1) disease (

Indexed as

chemical pathologyevolutionary fuzzy systemsimbalanced dataNiemann–Pick disease type C1 (NPC1) diseaseNMR analysisNMR-linked metabolomicssubgroup discovery

Identifiers

PMID37887404
PMCPMC10608721
OpenAlexW4387638471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.